Page last updated: 2024-10-25

cyclandelate and Peripheral Vascular Diseases

cyclandelate has been researched along with Peripheral Vascular Diseases in 10 studies

Cyclandelate: A direct-acting SMOOTH MUSCLE relaxant used to dilate BLOOD VESSELS.
cyclandelate : The ester obtained by formal condensation of mandelic acid and 3,3,5-tricyclohexanol. It is a direct-acting smooth muscle relaxant used to dilate blood vessels.

Peripheral Vascular Diseases: Pathological processes involving any one of the BLOOD VESSELS in the vasculature outside the HEART.

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-199010 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
VAN WIJK, TW2
NIEVEEN, J1
RODBARD, JA1
GILLHESPY, RO1
MATHIEU, L1
PERNOT, C1
METZ, J1
STREIFF, F1
BALLERINI, C1
FIORE, G1
MAHL, MM1
STARACE, G1
NOFERI, A1
PADULA, R1
SPENCER, AM1
KAPPERT, A1
LESLIE, RE1

Other Studies

10 other studies available for cyclandelate and Peripheral Vascular Diseases

ArticleYear
The treatment of peripheral vascular diseases with cyclospasmol (mandelic acid ester of 3, 5, 5-trimethylcyclohexanol).
    Angiology, 1953, Volume: 4, Issue:2

    Topics: Cyclandelate; Mandelic Acids; Muscle Relaxants, Central; Peripheral Vascular Diseases; Vascular Dise

1953
[Diagnosis and treatment of peripheral vascular diseases; experience with cyclospasmol].
    Nederlands tijdschrift voor geneeskunde, 1954, Jan-23, Volume: 98, Issue:4

    Topics: Cardiovascular Agents; Cyclandelate; Muscle Relaxants, Central; Peripheral Vascular Diseases; Vascul

1954
Treatment of peripheral vascular disease with cyclospasmol.
    Angiology, 1956, Volume: 7, Issue:1

    Topics: Cardiovascular Agents; Cyclandelate; Muscle Relaxants, Central; Peripheral Vascular Diseases; Vascul

1956
[Value of high doses of amygdalic ester of 3,5,5-trimethylcyclohexanol (cyclospasmol) in the treatment of peripheral vascular disorders].
    Revue medicale de Nancy, 1959, Volume: 84

    Topics: Cardiovascular Agents; Cyclandelate; Muscle Relaxants, Central; Peripheral Vascular Diseases; Vascul

1959
[Therapeutic activity of cyclospasmol (3,5,5-trimethylcyclohexanol mandelic ester) in coronary & peripheral vascular diseases; casuistic contribution].
    Gazzetta medica italiana, 1959, Volume: 118, Issue:4

    Topics: Coronary Disease; Cyclandelate; Muscle Relaxants, Central; Peripheral Vascular Diseases; Vascular Di

1959
Vasodilators and the use of cyclospasmol in peripheral vascular disease.
    Angiology, 1961, Volume: 12

    Topics: Cardiovascular Agents; Cyclandelate; Muscle Relaxants, Central; Peripheral Vascular Diseases; Vascul

1961
[Use of a product of esterification of mandelic acid with 3,5,5-triethylcyclohexanol (cyclospasmol) in the treatment of peripheral arteriopathy].
    Gazzetta medica italiana, 1960, Volume: 119

    Topics: Cyclandelate; Esterification; Mandelic Acids; Peripheral Arterial Disease; Peripheral Vascular Disea

1960
Cyclospasmol in the treatment of peripheral vascular disease.
    Journal of the American Podiatry Association, 1963, Volume: 53

    Topics: Arteriosclerosis Obliterans; Cyclandelate; Foot Diseases; Frostbite; Humans; Peripheral Vascular Dis

1963
[The treatment of peripheral circulation disorders with cyclospasmol].
    Schweizerische medizinische Wochenschrift, 1955, Mar-05, Volume: 85, Issue:10

    Topics: Cardiovascular Diseases; Cyclandelate; Cyclohexanes; Humans; Peripheral Vascular Diseases; Vascular

1955
Effects of cyclandelate (cyclospasmol) in treatment of circulatory disturbances.
    Texas state journal of medicine, 1960, Volume: 56

    Topics: Cyclandelate; Peripheral Vascular Diseases; Vascular Diseases; Vasodilator Agents

1960